[Commentary on] No differences in efficacy of atypical and typical antipsychotics in early psychosis, but side effects differ

Stroup, T. Scott; Jarskog, L. Fredrik
February 2011
Evidence Based Mental Health;Feb2011, Vol. 14 Issue 1, p25
Academic Journal
The article comments on a study on the comparison between atypical and typical antipsychotics. It references the study "Efficacy of atypical antipsychotics in the treatment of early psychosis: meta-analysis," by Nicolas A. Crossley et al, published in a 2010 issue of the "British Journal of Psychiatry." It looks into the aspects of tolerability of drugs rather than classification of typical versus atypical when selecting antipsychotic treatment.


Related Articles

  • The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis. Firth, J.; Stubbs, B.; Sarris, J.; Rosenbaum, S.; Teasdale, S.; Berk, M.; Yung, A. R. // Psychological Medicine;Jul2017, Vol. 47 Issue 9, p1515 

    Background. When used as an adjunctive with antipsychotics, certain vitamins and minerals may be effective for improving symptomatic outcomes of schizophrenia, by restoring nutritional deficits, reducing oxidative stress, or modulating neurological pathways. Method. We conducted a systematic...

  • Interventions for the prevention and treatment of postpartum psychosis: a systematic review. Doucet, Shelley; Jones, Ian; Letourneau, Nicole; Dennis, Cindy-Lee; Blackmore, Emma Robertson // Archives of Women's Mental Health;Apr2011, Vol. 14 Issue 2, p89 

    Postpartum psychosis is a serious disorder that can cause negative consequences for the mother, infant, and entire family. While reports of this condition date back for centuries, little is known about what interventions are most effective for this population. The purpose of this systematic...

  • Evidence for early intervention in first-episode psychosis. Sanbrook, Mark; Harris, Anthony // Canadian Journal of Psychiatry;Apr2004, Vol. 49 Issue 4, p280 

    Presents a letter to the editor on evidence for early intervention in the first-episode psychosis published in the April 2004 issue of "The Canadian Journal of Psychiatry."

  • Re: Evolutionary perspectives on schizophrenia. Karagianis, Jamie // Canadian Journal of Psychiatry;Oct2003, Vol. 48 Issue 9, p641 

    Presents a letter to the editor discussing evolutionary perspectives on schizophrenia.

  • Review: cognitive impairment present in people with affective psychoses.  // Evidence Based Mental Health;Nov2010, Vol. 13 Issue 4, p105 

    The article discusses a study which described the characteristics and level of cognitive impairment in people having affective psychoses (APs). Reliable tests used to measure effect size of difference in cognitive abilities measured over eight domains include general intelligence, mental speed,...

  • Ziprasidone in Parkinson's disease psychosis. Connemann, Bernhard J.; Schönfeldt-Lecuona, Carlos // Canadian Journal of Psychiatry;Jan2004, Vol. 49 Issue 1, p73 

    Presents a letter to the editor concerning the use of ziprasidone in treating Parkinson's disease psychosis.

  • Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Kishi, Taro; Matsuda, Yuki; Iwata, Nakao // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Background: The present study aimed to evaluate cardiometabolic risks [weight gain, blood lipid levels (total cholesterol and triglycerides), blood glucose levels, hemoglobin A1c (HbA1c) levels, and corrected QT interval (QTc) prolongation] associated with the use of blonanserin and perospirone...

  • Atypical antipsychotic use in treating adolescents and young adults with developmental disabilities. Friedlander, Robin; Lazar, Susan; Klancnik, Joseph; Friedlander, R; Lazar, S; Klancnik, J // Canadian Journal of Psychiatry;Oct2001, Vol. 46 Issue 8, p741 

    Objective: To study the usage, efficacy, and side effects patterns of atypical neuroleptics (atypicals) in adolescents and young adults with developmental disabilities (DDs) (mental retardation). Method: We undertook a chart review of adolescents and young adults (under...

  • Antipsychotic drugs and obesity: is prolactin involved? Baptista, Trino; Lacruz, Anny; Meza, Teraiza; Contreras, Quilianio; Delgado, Carlos; Mejias, Maria A; Hernàndez, Luis; Baptista, T; Lacruz, A; Meza, T; Contreras, Q; Delgado, C; Mejìas, M A; Hernàndez, L // Canadian Journal of Psychiatry;Nov2001, Vol. 46 Issue 9, p829 

    Objectives: To correlate the anthropometric indexes (Body Mass Index [BMI] and Waist-Hip ratio [WHR]) with the serum prolactin levels in a heterogeneous population of patients treated with typical antipsychotic (AP) drugs.Methods: We evaluated BMI, WHR, and fasting...

  • Assessing and monitoring antipsychotic-induced movement disorders in hospitalized patients: a cautionary study. Cortese, Leonardo; Jog, Mandar; McAuley, Jeffrey; Kotteda, V.; Costa, Giuseppe; McAuley, T Jeffrey // Canadian Journal of Psychiatry;Jan2004, Vol. 49 Issue 1, p31 

    Objective: To assess the amount of documentation and level of assessment provided by attending physicians and nursing staff in regard to extrapyramidal symptoms (EPS) experienced by hospitalized patients with varied DSM-IV diagnoses regularly treated with antipsychotic...


Read the Article

Other Topics